Form 8-K - Current report:
SEC Accession No. 0001753926-23-000765
Filing Date
2023-06-01
Accepted
2023-06-01 16:36:02
Documents
12
Period of Report
2023-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K g083578_8k.htm   iXBRL 8-K 32103
  Complete submission text file 0001753926-23-000765.txt   206421

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lipo-20230601.xsd EX-101.SCH 2956
3 XBRL LABEL FILE lipo-20230601_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lipo-20230601_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT g083578_8k_htm.xml XML 3773
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 23985252
SIC: 2834 Pharmaceutical Preparations